Next Article in Journal
Apoptotic Activity of New Oxisterigmatocystin Derivatives from the Marine-Derived Fungus Aspergillus nomius NC06
Previous Article in Journal
Natural Products from Actinomycetes Associated with Marine Organisms
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 19
Issue 11
10.3390/md19110630
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues

by
Sicheng Shen
1,
Weiping Wang
2,
Zijun Chen
1,
Huihui Zhang
1,
Yuchun Yang
1,
Xiaoliang Wang
2,
Peng Fu
3,* and
Bingnan Han
1,*
1
Department of Development Technology of Marine Resources, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China
2
Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
3
Key Laboratory of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2021, 19(11), 630; https://doi.org/10.3390/md19110630
Submission received: 16 September 2021 / Revised: 5 November 2021 / Accepted: 5 November 2021 / Published: 11 November 2021
Browse Figures
Versions Notes

Abstract

:
Potassium channel Kv1.5 has been considered a key target for new treatments of atrial tachyarrhythmias, with few side effects. Four new debromoaplysiatoxin analogues with a 6/6/12 fused ring system were isolated from marine cyanobacterium Lyngbya sp. Their planar structures were elucidated by HRESIMS, 1D and 2D NMR. The absolute configuration of oscillatoxin J (1) was determined by single-crystal X-ray diffraction, and the absolute configurations of oscillatoxin K (2), oscillatoxin L (3) and oscillatoxin M (4) were confirmed on the basis of GIAO NMR shift calculation followed by DP4 analysis. The current study confirmed the absolute configuration of the pivotal chiral positions (7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R) at traditional ATXs with 6/12/6 tricyclic ring system. Compound 1, 2 and 4 exhibited blocking activities against Kv1.5 with IC50 values of 2.61 ± 0.91 µM, 3.86 ± 1.03 µM and 3.79 ± 1.01 µM, respectively. However, compound 3 exhibited a minimum effect on Kv1.5 at 10 µM. Furthermore, all of these new debromoaplysiatoxin analogs displayed no apparent activity in a brine shrimp toxicity assay.

Graphical Abstract

1. Introduction

Many marine creatures have developed various ways to mark themselves as predators or preys over the course of evolution, and marine toxins have often played an important role in these relationships [1]. A variety of marine toxins block or activate ion channels [2,3,4,5,6]. For instance, conotoxins were discovered as mammalian voltage-gated potassium channel (Kv) 1 blockers [7], shellfish toxin saxitoxin (STXs) exhibited tetrodotoxin-sensitive voltage-gated sodium channels (Navs) blocking activity [8] and ciguatoxins, a kind of polyether toxins, acted as sodium channel activators [9]. Moreover, many cyanotoxins were identified as modulators of the sodium/ potassium channels [10,11,12,13,14].
Voltage-gated K+ channels (Kv) are membrane-inserted K+ selective protein complexes [15]. Kv channels are important for various physiological and pathophysiological processes [16,17]. The Shaker-related Kv1 family consisting of subtypes (Kv1.1–Kv1.8) present in most mammalian peripheral tissues such as cardiovascular, nervous and the immune system, and many of them have been identified as potential targets for a variety of marine toxins [18,19,20]. Dalazatide (ShK-186), targeting the Kv1.3 ion channel [21], has completed phase 1 clinical trials for the treatment of autoimmune diseases [22]. Gambierol, a marine polycyclic ether toxin produced by the dinoflagellate Gambierdiscus toxicus with IC50 of 34.5 ± 1.5 nM aganist Kv1.2 channel, might be deemed as a lead compound in further studies of the treatment of pathogenic conditions [23]. Two toxins identified from the venom of Bunodosoma caissarum, BcsTx1 and BcsTx2, displayed the highest affinity for Kv1.6 with IC50 of 1.31 ± 0.20 nM and 7.76 ± 1.90 nM, respectively [24].
The aplysiatoxins (ATXs) and their related analogues (oscillatoxins and nhatrangins) are distinct polyketide classes of marine toxins isolated from several cyanobacterial species, including Oscillatoria nigro-viridis, Schizothrix calcicola and Lyngbya majuscula [25,26,27,28]. In our previous studies, we have pre-screened many ATXs and debromoaplysiatoxin analogues (DATs) for inhibitory activity on the shaker-related subfamily of voltage-gated channels (Kv1.1–Kv1.5), and the results indicated that some analogues presented selective and strong blocking effects on potassium channel Kv1.5 [29]. The ultrarapid activating delayed rectifier K+ current (IKur) carried by the Kv1.5 channel is the main repolarization current in human atria but has no effect in the ventricle [30,31]. Therefore, Kv1.5 has become a significant molecular target for the treatment of atrial tachyarrhythmias with minimum side effects. In order to find additional novel Kv1.5 inhibitors, our team has isolated four new debromoaplysiatoxin analogues (Figure 1), oscillatoxin J–M (1–4) from the cyanobacterium Lyngbya sp. The planar structures of these compounds were elucidated by analysis of MS and NMR data, and the absolute configurations were determined by single-crystal X-ray diffraction combined with gauge invariant atomic orbital (GIAO) NMR shift calculation followed by DP4 analysis. DP4 is a probability analysis method based on the errors in each 13C or 1H chemical shift in the GIAO NMR calculation. The bioactivity results implicated that these four new DAT analogues and DAT exhibited differential Kv1.5 blocking activities and brine shrimp toxicities in correlation with the existence of structural functionality change.

2. Results and Discussion

2.1. Structure Elucidation

Oscillatoxin J (1), obtained as white solid ([α ] D 25 + 1.0 (c = 0.3, MeCN); UV (MeOH) λmax (log ε) 194 (3.91), 268 (2.47) nm (Figure S2.1.9)), was assigned to a molecular formula of C32H44O9 with 11 degrees of unsaturation, as established by HRESIMS at m/z 595.2886 [M + Na]+ (calcd for C32H44O9Na, 595.2883). Its 13C and DEPT NMR spectra exhibited 32 carbon signals, attributed to one methoxy, six methyls, four methylenes, thirteen methines and eight quaternary carbons (Table 1). The 1H NMR spectrum and the 13C NMR spectrum of 1 bore a close resemblance to that of oscillatoxin B1 [32], except a double bond between C-4 and C-5 instead of a hydroxyl group on C-4. The HMBC correlations of H-5 to C-3, C-4, C-6 and C-7 and H3-26 to C-3, C-4 and C-5 strongly supported this assignment. Hence, the planar structure of 1 was established. Furthermore, the structure of 1 was proved by X-ray analysis (Figure 2).
X-ray diffraction analysis of 1 with Cu Kα radiation established the absolute configuration of 1 to be 7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R with an absolute structure parameter of 0.06(18), consistent with the sequential correlations of H-9/H-10, H-10/H3-22 and H-11/H3-23 in the ROESY spectrum (Supplementary Information Figure S2.1.7).
Previously, only 19,21-dibromoaplysiatoxin [33] and neo-debromoaplysiatoxin A [34] were reported with the successful obtainment of crystal structures. In this study, the determination of absolute structure of oscillatoxin J by using X-ray diffraction analysis further confirmed the pivotal chiral positions (C-7, C-9/C-10/C-11/C-12, C-15 and C-29/C-30) of DATs with a 6/12/6 tricyclic ring system, which provided a reference for the determination of stereochemistry of the series of compounds.
Oscillatoxin K (2) was isolated as a white solid ([α ] D 25 + 64.4 (c = 0.36, MeCN); UV (MeOH) λmax (log ε) 198 (2.71), 275 (0.55) nm (Supplementary Information Figure S2.2.9)) with a molecular formula C32H46O10, as determined from the HRESIMS at m/z 613.2980 [M + Na]+ (calcd for C32H46O10Na, 613.2989). Thirty-two carbon resonances can be observed in 13C and DEPT spectra, including eight quaternary carbons, twelve methines, five methylenes and seven methyls (Figure 3). Its NMR data were similar to 2-hydorxyanhydroaplysiatoxin, except for the absence of a bromine atom on C-17 [28]. The detailed 1H and 13C NMR signal assignments and connectivity were determined from a combination of 1H-1H COSY, HSQC and HMBC data (Supplementary Information Figures S2.2.1–S2.2.6).
The relative configuration of compound 2 was ascertained by detailed Nuclear analysis Overhauser Effect Spectroscopy (NOESY) spectrum, the coupling constants, NMR analysis and biogenetically related configuration inference of compound 2. The NOE correlations between H-9 and H-8a and small couplings of H-9 to H-8b (J8b,9 =2.8 Hz) proved that H-9 showed an equatorial position on ring B. H-10 and H-11 were determined as axial orientation by the large coupling constant (J = 10.1 Hz) of H-10/H-11. On the basis of NOE correlation of H-11/H-12, Newman’s projection analysis of energy equivalent isomers using nuclear coupling constant information and steric hindrance (Figure 4) was performed. The analysis suggested a gauche conformer of H-11/H-12, which is possessed by oscillatoxin J–M (1-4). For compound 2, the three large groups (–OR1, –CH2R3 and –CH(CH3) R2) in model A2 were extremely close in space, causing a large steric hindrance; hence, model A2 was also eliminated. The 1H-1H coupling constant (1.8Hz) between H-11 and H-12 indicated that there was a gauche relationship between these two protons; thus, model A1 was excluded. H-11 and H-12 were oriented in the same plane, which was confirmed by remaining model A3. The NOESY spectrum correlations between H-9/H-10, H3-23/H-11/H-12 and H-10/H3-22 proved that these protons were had the same orientations. In addition, taking notice of the structural similarities of oscillatoxin J–M (1–4), these four compounds are likely to have a common biosynthetic origin [26]. The coupling constants (J = 11.9 Hz) of H-29/H-28a and (J = 2.1Hz) of H-29/H-28b, in keeping with those of aplysiatoxins, indicated the syn relationship between H-29 and H-30. The chemical shifts of H-15 and its coupling constants (J = 6.4 Hz) were similar to those of aplysiatoxins [33]. Simulated and experimental 13C NMR chemical shifts of 2a and 2b were used for DP4 probability analysis. The calculations were performed by using the density functional theory (DFT) as carried out in the Gaussian 09 [35]. The statistical results indicated the structural equivalence of 2 to 2a (98.61% probability). In summary, the absolute configuration of 2 was established as 2R, 7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R.
Oscillatoxin L (3) was obtained as a white solid ([α ] D 25 + 35 (c = 0.1, MeCN); UV (MeOH) λmax (log ε) 197 (2.57), 275 (0.78) nm (Supplementary Information Figure S2.3.9)). It has a molecular formula of C32H48O11, with nine degrees of unsaturation, as assigned by HR-ESI-MS data (m/z 631.3087 [M + Na]+, calculated for C32H48O11Na, 631.3094). The interpretation of the 1D and 2D NMR spectra indicated that the planar structure of 3 closely agreed with debromoaplysiatoxin except for a hydroxyl on C-4 in 3. The HMBC correlations of H3-26 to C-3, C-4 and C-5 and H-2 to C-1 and C-3 strongly supported this connection. By comparing the 1H chemical shift and coupling constant of 3 with that of DAT 3, it was observed that they have the same stereochemical properties as DAT, except for C-3 and C-4 [36]. The DP4 analysis was again applied to the simulated 13C NMR chemical shifts of the four possible epimers 3a–3d (Figure 5). The results showed that the correct structure of compound 3 is the epimer 3a, with 100% probability (Figure 5 and Table S1.4.8., Supplementary Materials Information). Hence, the absolute configuration of 3 was determined to be 3S, 4S, 7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R (Figure 5).
Oscillatoxin M (4) was isolated as a white solid ([α ] D 25 + 35 (c = 0.3, MeCN); UV (MeOH) λmax (log ε) 196 (2.52), 275 (0.59) nm (Figure S2.4.9)). The molecular formula of C32H46O10 with 10 degrees of unsaturation was inferred from HRESIMS data at m/z 613.2994 [M + Na]+ (calcd for C32H46O10Na, 613.2989). The inspection of spectral data showed that the planar structure of oscillatoxin M (4) was identical to that of debromoaplysiatoxin (5), with the exception that C-3 had a methyl group instead of a hydroxyl group, and C-4 had a ketone carbonyl group instead of a methyl group. The HMBC correlations of H-5 to C-3, C-4 and C-6; H3-26 to C-3 and C-4; and H-2 to C-1, C-3 and C-4 strongly support this assignment. The relative configuration of H-9/H-10/H-11/H-12, H-15 and H-29/H-30 in compound 4 was determined in accordance with that of compound 2. Furthermore, the results of DP4 statistical analysis using the 13C NMR chemical shift values proved that the correct structure for 4 is the epimer 4a (Figure 6 and Supplementary Information Table S1.4.11.). Finally, the absolute configuration of 4 was established as 3R, 7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R.

2.2. Bioactivities

2.2.1. Inhibitory Activities against Kv1.5

The Kv1.5 (ultra-fast-delay rectifier potassium channel) mediation of ultra-rapid delayed rectifier K+ current (IKur) is the main current in the repolarization process of atrial action potentials. Our previous research has highlighted the capability of ATXs as ion channel blockers [34,37]. Some compounds have blocked Kv1.5 with certain selectivity [29]. In this work, a dose–response study was conducted on compounds 1–4 to evaluate their inhibitory activity against Kv1.5. Our results showed that compounds 1, 2 and 4 had significant inhibitory effects on Kv1.5, with IC50 values of 2.61 ± 0.91 µM (Figure 7), 3.86 ± 1.03 µM (Figure 8) and 3.79 ± 1.01 µM (Figure 9), respectively. Compound 1, 2 and 4 all voltage dependently inhibited the Kv1.5 current (Supplementary Materials 1.3). The inhibition was stronger at 50 mV than other tested potentials. The voltage dependence supported the fact that three compounds preferentially affected the open state of the Kv1.5 channels. However, compound 3, oscillatoxin L, is structurally almost identical to DAT (IC50 = 1.28 ± 0.08 µM), except having an additional hydroxy motif on adjacent carbon C-4, exhibiting minimum effects on the modulation of Kv1.5 at 10 µM (Figure S1.3.1). Aplysiatoxin and its derivatives are activators of protein kinase C (PKC), which has been well researched [38]. In a previous study, we have demonstrated DAT strongly upregulating the expression of phosphor PKCδ in human hepatocellular carcinomas (HepG2) at 10 µM [29] and proposed the potential mechanism for DATs modulating the Kv channel by activating protein kinase C [39]. The results might indicate that the simple modifications of the functionalities on A ring system in DAT structure may affect either the interaction of PKC or the blocking site of the Kv1.5 ion channel. Consequently, determining the mechanism of Kv1.5 inhibition activity of DAT analogues will be our ongoing project.

2.2.2. Toxicity of Brine Shrimp

In order to understand the toxicity effect of such compounds, brine shrimp Artemia salina (A. salina) was used as a model organism. The investigation of brine shrimp toxicity of debromoaplysiatoxin (DAT) and four DAT analogs (oscillatoxin J, oscillatoxin K, oscillatoxin L and oscillatoxin M) isolated from marine cyanobacterium Lyngbya sp., was conducted. When DAT concentration was as low as 0.1 µM, the survival of Artemia salina (A. salina) began to be affected (Table S1.3.2.1). Compounds 1, 2, 3 and 4 had no apparent effect at 30 µM. As shown in Figure 10, compared to other tested derivatives, debromoaplysiatoxin was the most toxic compound (IC50 value = 0.34 ± 0.036 µM) (Figure S1.3.2.1). The current results with a previous study [37] indicated that the 3-hydroxy group at DAT seemed to play an important role in determining higher toxicity. However, the specific mechanism of toxic action of these compounds remains unclear, and further studies are needed.

3. Materials and Methods

3.1. General Experimental Procedure

UV was acquired on a UV/EV300 spectrometer (Thermo Scientific, Waltham, MA, USA), and IR spectra were obtained on a Nicolet iS20 instrument (Thermo Fisher Scientific, MA, USA). Optical rotation data were performed by a Jasco P-2000 polarimeter (Jasco, Hachiojishi, Tokyo, Japan). 1H and 13C NMR spectra were acquired on an Agilent 600 MHz spectrometer (Agilent Technologies, Santa Clara, CA, USA), with CDCl3 (δH 7.26 and δC 77.16) as the solvent and internal standard. HRESIMS data were collected with a Bruker micrOTOF-Q II mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany). A Shimadzu LC-16 series instrument (Shimadzu, Kyoto, Japan) was equipped with C-18 column (5 µm, 10 mm × 250 mm, YMC, Kyoto, Japan) and an SPD-M20A diode array detector (Shimadzu, Kyoto, Japan) for high-performance liquid chromatography (HPLC) analysis. For column chromatography, Silica gel 60 (200–300 mesh; Yantai, China) and octadecylsilyl (ODS) (50 µm, YMC, Kyoto, Japan) were used. A silica gel 60 F254 plate (Merck, Darmstadt, Germany) was used for analytical thin-layer chromatography.

3.2. Material

Cyanobacterium Lyngbya sp. was obtained from the harbor of Sanya, Hainan province, China, in November 2016. The sample was identified by Prof. Bing-Nan Han (Zhejiang Sci-Tech University, Zhejiang, China). After morphological and molecular identification, a voucher specimen (voucher number: BNH-201606; gene bank accession numbers: MH636576) has been well deposited in Zhejiang Sci-Tech University.

3.3. Extraction and Isolation

Cyanobacterium freeze-dried powder (150 g) was extracted with CH2Cl2/MeOH (1:1, v/v). The obtained extract was dissolved in 1 L of MeOH/H2O (9:1, v/v) and extracted with CH2Cl2 (3 × 1 L) in order to obtain the CH2Cl2 extract (20 g), which was subjected to vacuum liquid chromatography (VLC) over silica gel to obtain seven subfractions (F. A–G). The separation conditions of the gradient used gradients of PE/EtOAc (5:1, 2:1, 1:1, 1:2, 1:5, 0:1, v/v). F.B, (2000 mg) was further separated by reversed-phase octadecylsilyl silica (ODS) (UV detection at 254 nm, flow rate 20 mL/min, 10%–100% MeCN/H2O and 180 min) in order to acquire 17 subfractions (F.B.1–17). Subsequently, the subfraction F.B.7 (231 mg) was purified by semi-preparative HPLC (Shimadzu silgreen C-18, 70% MeCN/H2O, 2.0 mL/min and UV detection at 190 nm) to collect oscillatoxin J (8 mg), oscillatoxin K (15.2 mg), oscillatoxin L (3.7 mg) and oscillatoxin M (25.4 mg) (Supplementary Materials 1.2).

3.4. Ion Channel Inhibitory Experiment

3.4.1. Cell Culture

For culturing mouse L cells lacking thymidine kinase (LTK) cells stably expressing human Kv1.5 channels (LTK/Kv1.5), 10% fetal bovine serum (FBS), 10,000 U/ml penicillin G and 10 mg/ml streptomycin were added into Dulbecco’s Modified Eagle Media (DMEM). LTK/Kv1.5 cells were cultured in a 37 °C humidified incubator set to 5% CO2. The amount of 100 μg/ml Genetic (G418) was added into the culture media to select transgenic cells. When the cells grew to 75–85% confluence, they were passaged for subsequent electrophysiological records (Supplementary Materials 1.3.1.1).

3.4.2. Electrophysiology

LTK cells cultured for at least 24 h could be used for currents recording. For Kv1.5 potassium current recording, the recording micropipettes were pulled with a P97 microelectrode puller (Sutter, CA, USA) with a resistance of about 3 MΩ when filling with internal solution containing the following: KCl 140 mM, MgCl2 1 mM, EGTA 5 mM, HEPES 10 mM and MgATP 1 mM (pH was adjusted to 7.25 by KOH). The bath solution contained the following: NaCl 137 mM, KCl 5.4 mM, CaCl2 1.8 mM, MgCl2 1 mM, Glucose 10 mM and HEPES 10 mM (pH was adjusted to 7.4 by NaOH). Kv1.5 currents were recorded at room temperature (22–24 °C) by PulseMaster (Version 2.65, Heka, Lambrecht, Germany) via an EPC-10 USB amplifier (Heka, Lambrecht, Germany). In order to reduce recording errors, cells with seal resistance above 1 GΩ and series resistance that was fully compensated above 80% were used. Leak compensation was used to compensate the leak current and to subtract the capacitive artifacts (Supplementary Materials 1.3.1.2).

3.5. Brine Shrimp Toxicity Assay

Brine shrimp A. salina is an important model organism for ecosystems, and because of its high sensitivity and easy availability, it can be used in laboratory settings to study toxic effects and to provide safe results. A. salina or brine shrimp cysts were cultivated in 3.2% of saline water. After aeration with normal saline, cysts were placed at temperature for 24 h and then cultured. For toxicity screening, hatched larvae were collected and introduced in saline water. Add 0.9% brine and 30 larvae with good activity to each well to produce a 96-well test culture plate. New compounds of 0.1 µM, 1 µM, 10 µM and 30 µM and DAT were added to the experimental culture plate, respectively. Dimethyl sulfoxide (Aladdin, Shanghai, China) and dichloromethane (Aladdin, Shanghai, China) were added as blank control and positive control. The survival rate of A. salina was calculated after 24 h treatment at 25 °C.

4. Conclusions

In conclusion, four new debromoaplysiatoxin analogues, oscillatoxin J–M (1–4), were isolated from the cyanobacterium Lyngbya sp. The structures of the new compounds were characterized by 1D and 2D NMR and MS data. ATXs easily underwent structural rearrangement to form new structures with new functionality and new stereochemistry because of the presence of some unstable functional groups such as hemiacetal and ketal, etc. However, the current study confirmed the absolute configuration of pivotal chiral positions (7S, 9S, 10S, 11R, 12S, 15S, 29R and 30R) at traditional ATXs with 6/12/6 tricyclic ring system of compounds 1–4 via X-ray diffraction and GIAO NMR shift calculation followed by DP4 analysis. Compound 1, 2 and 4 showed inhibitory activities against Kv1.5 with IC50 value of 2.61 ± 0.91 µM, 3.86 ± 1.03 µM and 3.79 ± 1.01 µM, respectively. Compound 3 exhibited no apparent Kv1.5 inhibition activity at 10 µM. Discovery of new DAT analogs may highlight some insightful structures and activity relationships for developing strong, effective and safe Kv1.5 inhibitors in the future. Our future work will focus on characterizing the selectivity of these compounds for Kv1.5 and how they inhibit Kv1.5 channel.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/md19110630/s1, experimental details; Figure S1.1.: Identification of cyanobacterium; Figure S1.3.1.1.– S1.3.1.4.: Ion channel experiment; Table S1.3.2.1.: Brine shrimp cytotoxicity assay; Tables S1.4.1.–S1.4.11.: NMR calculation and followed by DP4 analysis; Figures S2.1.–S2.4.: 1D and 2D NMR, HRESIMS, UV and IR spectra of compounds 1–4.

Author Contributions

Performed the experiments for the isolation, structure elucidation and prepared the manuscript, S.S.; ion channel inhibitory activity evaluation, W.W. and X.W.; performed part of the experiments, Z.C., H.Z. and Y.Y.; performed DP4 calculations, P.F.; supervised research work and revised the manuscript, B.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (81973233), the Key Research and Development Program of Zhejiang Province, China (2021C02062), the Scientific Research Foundation of Zhejiang Sci-Tech University (17042058-Y) and the Special Program for Research and Development of Zhejiang Sci-Tech University (2019Y009).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data are contained within the article or Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mansbach, R.A.; Travers, T.; McMahon, B.H.; Fair, J.M.; Gnanakaran, S. Snails in Silico: A Review of Computational Studies on the Conopeptides. Mar. Drugs 2019, 17, 145. [Google Scholar] [CrossRef] [Green Version]
  2. Kalina, R.; Gladkikh, I.; Peigneur, S.; Dmitrenok, P.; Zelepuga, E.; Monastyrnaya, M.; Kozlovskaya, E.T. Type II toxins from sea anemone Heteractis crispa with various effects on activation and inactivation of voltage-gated sodium channels. Toxicon 2019, 159, 18. [Google Scholar] [CrossRef]
  3. Niklas, B.; Jankowska, M.; Gordon, D.; Béress, L.; Nowak, W.J.M. Interactions of Sea Anemone Toxins with Insect Sodium Channel-Insights from Electrophysiology and Molecular Docking Studies. Molecules 2021, 26, 1302. [Google Scholar] [CrossRef]
  4. Zhao, L.; Barber, L.M.; Hung, A. Modelling, Structural and dynamical effects of targeted mutations on μO-Conotoxin MfVIA: Molecular simulation studies. J. Mol. Graph. Model 2021, 102, 107777. [Google Scholar] [CrossRef]
  5. Sitprija, V.; Sitprija, S. Marine toxins and nephrotoxicity: Mechanism of injury. Toxicon 2019, 161, 44–49. [Google Scholar] [CrossRef] [PubMed]
  6. Baj, A.; Bistoletti, M.; Bosi, A.; Moro, E.; Crema, F. Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders. Toxins 2019, 11, 449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Finolurdaneta, R.K.; Belovanovic, A.; Micicvicovac, M.; Kinsella, G.K.; Mcarthur, J.R.; Alsabi, A. Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds. Mar. Drugs 2020, 18, 173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Adachi, K.; Ishizuka, H.; Odagi, M.; Nagasawa, K. Synthetic Approaches to Zetekitoxin AB, a Potent Voltage-Gated Sodium Channel Inhibitor. Mar. Drugs 2019, 18, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Mattei, C.; Vetter, I.; Eisenblätter, A.; Krock, B.; Ebbecke, M.; Desel, H.; Zimmermann, K. Ciguatera fish poisoning: A first epidemic in Germany highlights an increasing risk for European countries. Toxicon 2014, 91, 76–83. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Soria-Mercado, I.E.; Pereira, A.; Cao, Z.; Murray, T.F.; Gerwick, W.H. Alotamide A, a novel neuropharmacological agent from the marine cyanobacterium Lyngbya bouillonii. Org. Lett. 2009, 11, 4704. [Google Scholar] [CrossRef] [Green Version]
  11. Pereira, A.; Cao, Z.; Murray, T.F.; Gerwick, W.H. Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria. Chem. Biol. 2009, 16, 893–906. [Google Scholar] [CrossRef] [Green Version]
  12. Li, W.I.; Berman, F.W.; Okino, T.; Yokokawa, F.; Shioiri, T.; Gerwick, W.H.; Murray, T.F. Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels. Proc. Natl. Acad. Sci. USA 2001, 98, 7599–7604. [Google Scholar] [CrossRef] [Green Version]
  13. Nogle, L.M.; Okino, T.; Gerwick, W.H. Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2001, 64, 983–985. [Google Scholar] [CrossRef]
  14. Min, W.; Okino, T.; Nogle, L.M.; Marquez, B.L.; Gerwick, W.H. Structure, Synthesis, and Biological Properties of Kalkitoxin, a Novel Neurotoxin from the Marine Cyanobacterium Lyngbya majuscula. J. Am. Chem. Soc. 2000, 122, 12041–12042. [Google Scholar]
  15. Armstrong, C.M. Voltage-gated K channels. Sci. STKE 2003, 2003, re10. [Google Scholar] [CrossRef]
  16. Wulff, H.; Castle, N.A.; Pardo, L.A. Voltage-gated potassium channels as therapeutic targets. Nat. Rev. Drug Discov. 2009, 8, 982–1001. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Finol-Urdaneta, R.K.; Remedi, M.S.; Raasch, W.; Becker, S.; Clark, R.B.; Strüver, N.; Pavlov, E.; Nichols, C.G.; French, R.J.; Terlau, H. Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion. EMBO Mol. Med. 2012, 4, 424–434. [Google Scholar] [CrossRef] [PubMed]
  18. D’Adamo, M.C.; Liantonio, A.; Rolland, J.F.; Pessia, M.; Imbrici, P. Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches. Int. J. Mol. Sci. 2020, 21, 2935. [Google Scholar] [CrossRef] [PubMed]
  19. Baell, J.B.; Gable, R.W.; Harvey, A.J.; Toovey, N.; Herzog, T.; Hänsel, W.; Wulff, H. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: Synthesis and immunosuppressive activity. J. Med. Chem. 2004, 47, 2326–2336. [Google Scholar] [CrossRef] [PubMed]
  20. Peukert, S.; Brendel, J.; Pirard, B.; Brüggemann, A.; Below, P.; Kleemann, H.W.; Hemmerle, H.; Schmidt, W. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5. J. Med. Chem. 2003, 46, 486–498. [Google Scholar] [CrossRef]
  21. Pennington, M.W.; Harunur Rashid, M.; Tajhya, R.B.; Beeton, C.; Kuyucak, S.; Norton, R.S. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3. FEBS Lett. 2012, 586, 3996–4001. [Google Scholar] [CrossRef] [Green Version]
  22. Prentis, P.J.; Pavasovic, A.; Norton, R.S. Sea Anemones: Quiet Achievers in the Field of Peptide Toxins. Toxins 2018, 10, 36. [Google Scholar] [CrossRef] [Green Version]
  23. Cuypers, E.; Abdel-Mottaleb, Y.; Kopljar, I.; Rainier, J.D.; Raes, A.L.; Snyders, D.J.; Tytgat, J. Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels. Toxicon 2008, 51, 974–983. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Orts, D.J.; Peigneur, S.; Madio, B.; Cassoli, J.S.; Montandon, G.G.; Pimenta, A.M.; Bicudo, J.E.; Freitas, J.C.; Zaharenko, A.J.; Tytgat, J. Biochemical and electrophysiological characterization of two sea anemone type 1 potassium toxins from a geographically distant population of Bunodosoma caissarum. Mar. Drugs 2013, 11, 655–679. [Google Scholar] [CrossRef] [Green Version]
  25. Mynderse, J.S.; Moore, R.E. Toxins from blue-green algae: Structures of oscillatoxin A and three related bromine-containing toxins. J. Org. Chem. 1978, 43, 2301–2303. [Google Scholar] [CrossRef]
  26. Chlipala, G.E.; Pham, H.T.; Nguyen, V.H.; Krunic, A.; Shim, S.H.; Soejarto, D.D.; Orjala, J. Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J. Nat. Prod. 2010, 73, 784–787. [Google Scholar] [CrossRef] [Green Version]
  27. Nagai, H.; Sato, S.; Iida, K.; Hayashi, K.; Kawaguchi, M.; Uchida, H.; Satake, M. Oscillatoxin I: A New Aplysiatoxin Derivative, from a Marine Cyanobacterium. Toxins 2019, 11, 366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Nagai, H.; Watanabe, M.; Sato, S.; Kawaguchi, M.; Xiao, Y.Y.; Hayashi, K.; Watanabe, R.; Uchida, H.; Satake, M. New aplysiatoxin derivatives from the Okinawan cyanobacterium Moorea producens. Tetrahedron 2019, 75, 2486–2494. [Google Scholar] [CrossRef]
  29. Tang, Y.H.; Wu, J.; Fan, T.T.; Zhang, H.H.; Han, B.N. Chemical and biological study of aplysiatoxin derivatives showing inhibition of potassium channel Kv1.5. RSC Adv. 2019, 9, 7594–7600. [Google Scholar] [CrossRef] [Green Version]
  30. Bhuyan, R.; Seal, A. Dynamics and modulation studies of human voltage gated Kv1.5 channel. J. Biomol. Struct. Dyn. 2017, 35, 380–398. [Google Scholar] [CrossRef]
  31. Li, D.; Sun, H.; Levesque, P. Antiarrhythmic drug therapy for atrial fibrillation: Focus on atrial selectivity and safety. Cardiovasc. Hematol. Agents Med. Chem. 2009, 7, 64–75. [Google Scholar] [CrossRef] [PubMed]
  32. Entzeroth, M.; Blackman, A.J.; Mynderse, J.S.; Moore, R.E. Structures and stereochemistries of oscillatoxin B, 31-noroscillatoxin B, oscillatoxin D, and 30-methyloscillatoxin D. J. Org. Chem. 1985, 16, 1255–1259. [Google Scholar] [CrossRef]
  33. Moore, R.E.; Blackman, A.J.; Cheuk, C.; Mynderse, J.S.; Matsumoto, G.K.; Clardy, J.; Woodard, R.W.; Craig, J.C. Absolute stereochemistries of the aplysiatoxins and oscillatoxin A. J. Org. Chem. 1983, 49, 2484–2489. [Google Scholar] [CrossRef]
  34. Han, B.N.; Liang, T.T.; Keen, L.J.; Fan, T.T.; Zhang, X.D.; Xu, L.; Zhao, Q.; Wang, S.P.; Lin, H.W. Two Marine Cyanobacterial Aplysiatoxin Polyketides, Neo-debromoaplysiatoxin A and B, with K(+) Channel Inhibition Activity. Org. Lett. 2018, 20, 578–581. [Google Scholar] [CrossRef] [PubMed]
  35. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A. Gaussian 09; Revision B.01; Gaussian Inc.: Wallingford, CT, USA, 2010. [Google Scholar]
  36. Nagai, H.; Yasumoto, T.; Hokama, Y. Manauealides, some of the causative agents of a red alga Gracilaria coronopifolia poisoning in Hawaii. J. Nat. Prod. 1997, 60, 925–928. [Google Scholar] [CrossRef] [PubMed]
  37. Zhang, H.H.; Zhang, X.K.; Si, R.R.; Shen, S.C.; Liang, T.T.; Fan, T.T.; Chen, W.; Xu, L.H.; Han, B.N. Chemical and Biological Study of Novel Aplysiatoxin Derivatives from the Marine Cyanobacterium Lyngbya sp. Toxins 2020, 12, 733. [Google Scholar] [CrossRef]
  38. Suganuma, M.; Fujiki, H.; Tahira, T.; Cheuk, C.; Moore, R.E.; Sugimura, T. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins. Carcinogenesis 1984, 5, 315–318. [Google Scholar] [CrossRef]
  39. Fan, T.T.; Zhang, H.H.; Tang, Y.H.; Zhang, F.Z.; Han, B.N. Two New Neo-debromoaplysiatoxins-A Pair of Stereoisomers Exhibiting Potent Kv1.5 Ion Channel Inhibition Activities. Mar. Drugs 2019, 17, 652. [Google Scholar] [CrossRef] [Green Version]
Marinedrugs 19 00630 g001 550
Figure 1. Structures of identified debromoaplysiatoxin analogues in this study: new compounds 1–4 and reported Compound 5.
Figure 1. Structures of identified debromoaplysiatoxin analogues in this study: new compounds 1–4 and reported Compound 5.
Marinedrugs 19 00630 g001
Marinedrugs 19 00630 g002 550
Figure 2. Key 2D correlations and X-ray structure of 1.
Figure 2. Key 2D correlations and X-ray structure of 1.
Marinedrugs 19 00630 g002
Marinedrugs 19 00630 g003 550
Figure 3. (A) Key 2D correlations of 2. (B) Key NOESY correlations of 2 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 2.
Figure 3. (A) Key 2D correlations of 2. (B) Key NOESY correlations of 2 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 2.
Marinedrugs 19 00630 g003
Marinedrugs 19 00630 g004 550
Figure 4. Newman projection analysis of the energy equivalent isomer.
Figure 4. Newman projection analysis of the energy equivalent isomer.
Marinedrugs 19 00630 g004
Marinedrugs 19 00630 g005 550
Figure 5. (A) Key 2D correlations of 3. (B) Key NOESY correlations of 3 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 3.
Figure 5. (A) Key 2D correlations of 3. (B) Key NOESY correlations of 3 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 3.
Marinedrugs 19 00630 g005
Marinedrugs 19 00630 g006 550
Figure 6. (A) Key 2D correlations of 4. (B) Key NOESY correlations of 4 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 4.
Figure 6. (A) Key 2D correlations of 4. (B) Key NOESY correlations of 4 (solid lines: α-orientation; dashed lines: β-orientation). (C) DP4 analysis results for 4.
Marinedrugs 19 00630 g006
Marinedrugs 19 00630 g007 550
Figure 7. (A) Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin J (1). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin J (1). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 2.61 ± 0.91 µM.
Figure 7. (A) Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin J (1). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin J (1). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 2.61 ± 0.91 µM.
Marinedrugs 19 00630 g007
Marinedrugs 19 00630 g008 550
Figure 8. (A) Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin K (2). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin K (2). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 3.86 ± 1.03 µM.
Figure 8. (A) Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin K (2). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin K (2). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 3.86 ± 1.03 µM.
Marinedrugs 19 00630 g008
Marinedrugs 19 00630 g009 550
Figure 9. Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin M (4). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin M (4). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 3.79 ± 1.01 µM.
Figure 9. Kv1.5 currents were evoked by a 300 ms depolarizing pulse from –50 mV to 50 mV in 20 mV increments from a holding potential of –70 mV in the absence and presence of 0.3 μM, 1 μM, 3 μM and 10 μM oscillatoxin M (4). The current amplitudes were measured at the end of the 300 ms pulse at 50 mV. (B) Concentration–inhibition curve expressed in %. The abscissa represents the concentration, and the ordinate represents the percentage of Kv1.5 current that is blocked at different concentrations of oscillatoxin M (4). Data points represent mean ± SEM of 3 to 5 measurements, and the inhibitory effect showed an IC50 value of 3.79 ± 1.01 µM.
Marinedrugs 19 00630 g009
Marinedrugs 19 00630 g010 550
Figure 10. Dose effect of compounds 1–4 to Artemia salina (A. salina). A. salina was treated with indicated concentration (1 µM and 30 µM) of dichloromethane (DCM), debromoaplysiatoxin (DAT) and compounds 1–4 for 24 h. (A) The percentage of A. salina compounds 1–4 in 1 µM; (B) the percentage of A. salina with compounds 1–4 in 30 µM. N.D: the life of brine shrimp not detected. Data were analyzed by GraphPad prism (Table S1.3.2.1).
Figure 10. Dose effect of compounds 1–4 to Artemia salina (A. salina). A. salina was treated with indicated concentration (1 µM and 30 µM) of dichloromethane (DCM), debromoaplysiatoxin (DAT) and compounds 1–4 for 24 h. (A) The percentage of A. salina compounds 1–4 in 1 µM; (B) the percentage of A. salina with compounds 1–4 in 30 µM. N.D: the life of brine shrimp not detected. Data were analyzed by GraphPad prism (Table S1.3.2.1).
Marinedrugs 19 00630 g010
Table
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR data for compounds 1–4 in CDCl3 (δ in ppm; J in Hz).
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR data for compounds 1–4 in CDCl3 (δ in ppm; J in Hz).
Pos.1234
δH (J in Hz)δCδH (J in Hz)δCδH (J in Hz)δCδH (J in Hz)δC
1 169.0 171.1 174.2 166.2
25.04, s95.05.04, s70.2a 3.00, d (11.7)40.03.36, d (13.3)46.3
b 2.45, d (11.7)3.68, d (13.3)
3 159.3 140.2 101.1 86.3
4 124.3 110.3 72.6 203.2
55.67, s140.8a 2.25, m39.9a 3.00, d (11.7)43.4a 1.43, m44.9
b 1.33, d (16.9)b 2.45, d (11.7) b 2.65, d (12.7)
6 39.8 35.7 37.7 47.1
7 102.5 99.9 102.0 108.7
8a 2.56, d (14.9)30.7a 1.64, m30.4a 2.13, dd (15.0, 2.8)32.8a 2.34, dd (14.6, 3.3)31.6
b 1.65, mb 2.27, m (2.8)b 1.53, dd (14.9, 3.6)b 1.41(m)
94.8, m73.64.84, q (2.9)74.34.82, q (3.1)73.34.75, q (2.8)74.2
101.67, m34.41.60, ddd (10.1, 6.8, 2.8)34.11.14, m33.91.56, m34.1
113.80, d (10.5)71.73.54, dd (10.6, 1.8)72.03.65, dd (10.8, 1.9)72.63.63, dd (10.6, 1.9)73.7
121.47, m33.11.25, m33.51.59, dt (6.9, 3.3)33.51.32, m33.8
13a 1.36, d (6.6)30.5a 1.36, m30.3a 1.39, td (13.7, 12.1, 6.6)30.0a 1.25, m30.0
b 1.33, d (6.6)b 1.28, mb 1.27, d (14.6) b 1.19, m
14a 1.68, m35.9a 1.83, m36.0a 1.95, m36.1a 1.89, m36.2
b 1.53, mb 1.62, m b 1.5, mb 1.52, m
153.93, dd (8.4, 4.8)84.94.01, t (6.8)85.04.06, t (6.9)84.84.07, dd (7.7, 5.6)84.8
16 144.1 144.4 144.1 144.1
176.8, m117.86.85, dt (7.6, 1.2)118.56.87, m118.26.90, dt (7.6, 1.2)118.3
187.20, d (7.7)129.77.18, t (7.8)129.67.22, t (7.8)129.97.20, t (7.8)129.8
196.71, dt (7.9, 1,1)115.26.72, ddd (8.1, 2.6, 1.0)114.56.88, m114.76.84, t (1.9)114.9
20 156.8 156.2 155.9 155.9
216.8, m114.06.89, t (2.0) 114.46.76, ddd (8.0, 2.5, 1.0)114.86.75, m114.6
220.77, overlap12.80.75, d (6.5)12.00.63, d (6.9)13.80.71, d (6.7)11.3
230.78, overlap13.40.73, d (6.9)13.40.73, d (6.9)12.20.78, d (6.8)13.8
240.99, s23.60.8, s22.80.86, s27.10.97, s23.6
251.05, s23.50.9, s24.41.12, s 26.51.00, s25.6
261.68, m17.61.66, s16.91.20, s18.11.47, s27.2
27 170.7 169.8 169.9 170.1
28a 2.88, dd (14.9, 5.6)36.6a 2.96, dd (17.9, 11.9)36.9a 2.80, m35.4a 2.96, dd (18.7, 11.2)35.6
b 2.63, dd (14.9, 4.9)b 2.70, dd (17.9, 2.1)b 2.79, mb 2.70, dd (18.7, 1.3)
295.14, d (5.2)75.05.42, ddd (11.9, 5.0, 2.1)74.05.3, dt (9.8, 5.0)74.65.35, dd (11.4, 4.6)74.0
304.27, p (6.3)68.63.82, m68.94.02, m67.93.81, m68.7
311.27, q (6.7)18.91.23, d (6.4)19.91.21, d (5.1)26.41.15, d (6.4)19.1
15-OCH33.2, s56.93.23, s56.73.24, s56.93.26, s56.8
NMR data of debromoaplysiatoxin (DAT) in Table S3 of Supplementary Materials.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shen, S.; Wang, W.; Chen, Z.; Zhang, H.; Yang, Y.; Wang, X.; Fu, P.; Han, B. Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues. Mar. Drugs 2021, 19, 630. https://doi.org/10.3390/md19110630

AMA Style

Shen S, Wang W, Chen Z, Zhang H, Yang Y, Wang X, Fu P, Han B. Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues. Marine Drugs. 2021; 19(11):630. https://doi.org/10.3390/md19110630

Chicago/Turabian Style

Shen, Sicheng, Weiping Wang, Zijun Chen, Huihui Zhang, Yuchun Yang, Xiaoliang Wang, Peng Fu, and Bingnan Han. 2021. "Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues" Marine Drugs 19, no. 11: 630. https://doi.org/10.3390/md19110630

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop